Prosensa Provides Update on Drisapersen
May 01, 2014 06:58 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, May 1, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) the Dutch
biopharmaceutical company focusing on rare diseases with a high
unmet medical need, yesterday...
Prosensa to Present at the 66th Annual American Academy of Neurology (AAN) Annual Meeting and the 39th Annual Deutsche Bank Health Care Conference
April 28, 2014 08:00 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, April 28, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) the Dutch biopharmaceutical
company focusing on rare diseases with a high unmet medical need,
today...
Prosensa to Appoint Michael Wyzga to Supervisory Board
April 08, 2014 08:00 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, April 8, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), the Dutch
biopharmaceutical company focusing on rare diseases with a high
unmet medical need, today...
Prosensa Announces Full Year 2013 Financial Results and Recent Corporate Developments
March 18, 2014 07:00 ET
|
Prosensa Holding N.V.
LEIDEN, The Netherlands, March 18, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (Nasdaq:RNA), the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high...
Prosensa Announces 48-Week Data from a U.S. Phase II Placebo-Controlled Study of Drisapersen in 51 DMD Boys
March 17, 2014 18:00 ET
|
Prosensa Holding N.V.
Chicago, IL, March 17, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), the Dutch
biopharmaceutical company focusing on RNA-modulating therapeutics
for rare diseases with high unmet need,...
Prosensa to Present at Upcoming Investor Conferences
March 06, 2014 08:00 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, March 6, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) announced
today announced presentations at upcoming investor conferences.
Celia Economides, Senior...
Prosensa Holding N.V. to Webcast Conference Call Discussing Full Year 2013 Financial Results and Corporate Update on March 18, 2014
March 05, 2014 10:18 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, March 5, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) today announced that the
Company will host a conference call and live audio webcast on
Tuesday, March 18,...
Prosensa to Participate at Upcoming Investor Conferences
January 31, 2014 09:16 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, Jan. 31, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) announced
today that it is schedule to participate at the following investor
conferences in...
Prosensa Reports Initial Findings from the Further Clinical Data Analyses of Drisapersen for the Treatment of Duchenne Muscular Dystrophy
January 16, 2014 12:35 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, Jan. 16, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), the Dutch biopharmaceutical
company focusing on RNA-modulating therapeutics for rare diseases
with high...
Prosensa to Provide Corporate Update to Key Stakeholders
January 13, 2014 15:09 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, Jan. 13, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), the Dutch biopharmaceutical
company focusing on RNA-modulating therapeutics for rare diseases
with high...